当前位置:首页 > 报告详情

为什么新型转基因生物与传统育种方式不相等.pdf

上传人: 表表 编号:1279901 2026-07-18 14页 1.41MB

1、Legal framework conditions and New GMOs on the market:Challenges for the European food and feed sectorWhy New GMOs are not equivalent to conventional breedingDr Margret EngelhardHead of Department GMO Regulation,Federal Agency for Nature conservation,Germanywww.bfn.dereimax16 Why New GMOs are not eq

2、uivalent to conventional breedingDr.Margret Engelhard Federal Agency for Nature Conservation(BfN),Germany Non-GMO summit 13.05.2026SequencingSynthesisAutomatization Genome editing(CRISPR/cas)Genomes of organisms can now be shaped,redesigned and even shuffled to a revolutionary new extend,no matter i

3、f foreign genes are introduced or not.Technical transitions in biotechnology1Convergence of synthetic biology and generative AI RiskEquivalence Breeding Key Elements of the Dialogue on Regulation of NGT plants3334Equivalence between NGT 1-derived and conventionally bred plants is not scientifically

4、substantiatedQuestions or comments?Feel free to reach out:juliane.mundorfbfn.dePeer-reviewed publicationMundorf,J.,Simon,S.&Engelhard,M.The European Commissions regulatory proposal on new genomic techniques in plants:a focus on equivalence,complexity,and artificial intelligence.Environ Sci Eur 37,14

5、3(2025).https:/doi.org/10.1186/s12302-025-01199-2 Christian Kantner/Umweltbundesamtgenetic context,mutational bias,functional effects are overlooked.Modern gene editing can create(de novo)genetic modifications beyond the realistic capabilities of conventional breeding.Study by eight European environ

6、mental agencies:Differences to breedingSource:https:/www.bafu.admin.ch/bafu/en/home/topics/biotechnology/info-specialists/ig-gmo.html35Analysis from experts of five European environmental agencies Naturalness is not a criterion for safety No suitable denominators exists for per se risk assessment ht

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1. **新GMO(NGT)与常规育种不等效**:欧洲八国环境机构研究指出,NGT1(基因组编辑)植物与常规育种在遗传背景、突变偏差和功能效应上存在根本差异,不能简单视为等效。 2. **风险不容忽视**:94%的NGT植物应用属NGT1类别,部分(如RNAi技术)具明确风险(如杀虫),且"熟悉性"不排除安全隐患。 3. **监管需坚持个案评估**:欧盟148例案例显示,取消个案风险评估可能导致监管漏洞,尤其对AI设计的复杂性状。 4. **核心数据**:NGT1占商业应用 pipeline 的94%(60例),NGT2仅1例,传统转基因GMO占15例。 5. **结论**:"等效"非安全标准,需遵循预防原则,非转基因和有机标签重要性将提升。
**新GMO安全吗?** **基因编辑≠传统育种?** **NGT1风险被低估?**
客服
商务合作
小程序
服务号
折叠